BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 9359430)

  • 1. Functional conformations of the nuclear 1alpha,25-dihydroxyvitamin D3 receptor.
    Nayeri S; Carlberg C
    Biochem J; 1997 Oct; 327 ( Pt 2)(Pt 2):561-8. PubMed ID: 9359430
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The high affinity ligand binding conformation of the nuclear 1,25-dihydroxyvitamin D3 receptor is functionally linked to the transactivation domain 2 (AF-2).
    Nayeri S; Kahlen JP; Carlberg C
    Nucleic Acids Res; 1996 Nov; 24(22):4513-8. PubMed ID: 8948643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of functional vitamin D(3) receptor conformations on DNA-dependent vitamin D(3) signaling.
    Quack M; Carlberg C
    Mol Pharmacol; 2000 Feb; 57(2):375-84. PubMed ID: 10648648
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural variants of the vitamin D analogue EB1089 reduce its ligand sensitivity and promoter selectivity.
    Quack M; Clarin A; Binderup E; Björkling F; Hansen CM; Carlberg C
    J Cell Biochem; 1998 Dec; 71(3):340-50. PubMed ID: 9831071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-affinity nuclear receptor binding of 20-epi analogues of 1,25-dihydroxyvitamin D3 correlates well with gene activation.
    Nayeri S; Mathiasen IS; Binderup L; Carlberg C
    J Cell Biochem; 1996 Sep; 62(3):325-33. PubMed ID: 8872604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamics of 1α,25-dihydroxyvitamin D3-dependent chromatin accessibility of early vitamin D receptor target genes.
    Seuter S; Pehkonen P; Heikkinen S; Carlberg C
    Biochim Biophys Acta; 2013 Dec; 1829(12):1266-75. PubMed ID: 24185200
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allosteric interaction of the 1alpha,25-dihydroxyvitamin D3 receptor and the retinoid X receptor on DNA.
    Kahlen JP; Carlberg C
    Nucleic Acids Res; 1997 Nov; 25(21):4307-13. PubMed ID: 9336462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between Structure and Conformational Change of the Vitamin D Receptor Ligand Binding Domain in 1α,25-Dihydroxyvitamin D3 Signaling.
    Wan LY; Zhang YQ; Chen MD; Du YQ; Liu CB; Wu JF
    Molecules; 2015 Nov; 20(11):20473-86. PubMed ID: 26593892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Response element and coactivator-mediated conformational change of the vitamin D(3) receptor permits sensitive interaction with agonists.
    Herdick M; Bury Y; Quack M; Uskokovic MR; Polly P; Carlberg C
    Mol Pharmacol; 2000 Jun; 57(6):1206-17. PubMed ID: 10825392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 25-Dehydro-1alpha-hydroxyvitamin D3-26,23S-lactone antagonizes the nuclear vitamin D receptor by mediating a unique noncovalent conformational change.
    Bula CM; Bishop JE; Ishizuka S; Norman AW
    Mol Endocrinol; 2000 Nov; 14(11):1788-96. PubMed ID: 11075812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular basis of the selective activity of vitamin D analogues.
    Carlberg C
    J Cell Biochem; 2003 Feb; 88(2):274-81. PubMed ID: 12520526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distinct conformations of vitamin D receptor/retinoid X receptor-alpha heterodimers are specified by dinucleotide differences in the vitamin D-responsive elements of the osteocalcin and osteopontin genes.
    Staal A; van Wijnen AJ; Birkenhäger JC; Pols HA; Prahl J; DeLuca H; Gaub MP; Lian JB; Stein GS; van Leeuwen JP; Stein JL
    Mol Endocrinol; 1996 Nov; 10(11):1444-56. PubMed ID: 8923469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Why do we need a three-dimensional architecture of the ligand-binding domain of the nuclear 1alpha,25-dihydroxyvitamin D(3) receptor?
    Mohr SC; Swamy N; Xu W; Ray R
    Steroids; 2001; 66(3-5):189-201. PubMed ID: 11179726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene regulatory potential of nonsteroidal vitamin D receptor ligands.
    Peräkylä M; Malinen M; Herzig KH; Carlberg C
    Mol Endocrinol; 2005 Aug; 19(8):2060-73. PubMed ID: 15860548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligand-mediated conformational changes of the VDR are required for gene transactivation.
    Carlberg C
    J Steroid Biochem Mol Biol; 2004 May; 89-90(1-5):227-32. PubMed ID: 15225776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The concept of multiple vitamin D signaling pathways.
    Carlberg C
    J Investig Dermatol Symp Proc; 1996 Apr; 1(1):10-4. PubMed ID: 9627685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence for ligand-dependent intramolecular folding of the AF-2 domain in vitamin D receptor-activated transcription and coactivator interaction.
    Masuyama H; Brownfield CM; St-Arnaud R; MacDonald PN
    Mol Endocrinol; 1997 Sep; 11(10):1507-17. PubMed ID: 9280066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of the T-box for the function of the vitamin D receptor on different types of response elements.
    Quack M; Szafranski K; Rouvinen J; Carlberg C
    Nucleic Acids Res; 1998 Dec; 26(23):5372-8. PubMed ID: 9826761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structural evaluation of the agonistic action of a vitamin D analog with two side chains binding to the nuclear vitamin D receptor.
    Väisänen S; Peräkylä M; Kärkkäinen JI; Uskokovic MR; Carlberg C
    Mol Pharmacol; 2003 Jun; 63(6):1230-7. PubMed ID: 12761332
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
    Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
    J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.